Clinical Trial Update: Study of High Dose Interleukin-2 (IL-2) and Stereotactic Body Radiation (SBRT) in Patients With Metastatic Renal Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating high-dose interleukin-2 in combination with stereotactic body radiation therapy for metastatic renal cell carcinoma; the trial is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Providence Health & Services | Conditions: Renal Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING